851776-64-2 Usage
Molecular Structure
1-benzyl-5-oxo-1,4,5,6-tetrahydrocyclopenta[c]pyrazole-3-carbonitrile has a complex molecular structure, which includes a pyrazole ring and a cyclopentane ring.
Heterocyclic Compound
It is a heterocyclic compound, meaning it contains at least one ring structure with both carbon and non-carbon atoms.
Benzyl Group
The presence of a benzyl group (C6H5-CH2-) in its structure contributes to its chemical reactivity and stability.
Carbonitrile Group
The presence of a carbonitrile group (C≡N) enhances the chemical reactivity of the compound and may contribute to its potential pharmacological properties.
Chemical Reactivity
The compound has significant chemical reactivity due to the presence of both a benzyl group and a carbonitrile group.
Medicinal Chemistry Applications
1-benzyl-5-oxo-1,4,5,6-tetrahydrocyclopenta[c]pyrazole-3-carbonitrile has potential applications in the field of medicinal chemistry and drug discovery.
Pharmacological Properties
The unique structure of the compound may exhibit pharmacological properties, making it a potential candidate for further research and development.
Organic Synthesis
The compound can be used in organic synthesis, as a building block for the creation of new chemical entities.
Building Block
It serves as a building block for the development of novel pharmaceuticals and materials.
Further Research
Exploring the properties of 1-benzyl-5-oxo-1,4,5,6-tetrahydrocyclopenta[c]pyrazole-3-carbonitrile may lead to the development of new drugs and materials.
Check Digit Verification of cas no
The CAS Registry Mumber 851776-64-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,5,1,7,7 and 6 respectively; the second part has 2 digits, 6 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 851776-64:
(8*8)+(7*5)+(6*1)+(5*7)+(4*7)+(3*6)+(2*6)+(1*4)=202
202 % 10 = 2
So 851776-64-2 is a valid CAS Registry Number.
851776-64-2Relevant articles and documents
GPR109a agonists. Part 1: 5-Alkyl and 5-aryl-pyrazole-tetrazoles as agonists of the human orphan G-protein coupled receptor GPR109a
Imbriglio, Jason E.,Chang, Sookhee,Liang, Rui,Raghavan, Subharekha,Schmidt, Darby,Smenton, Abby,Tria, Scott,Schrader, Thomas O.,Jung, Jae-Kyu,Esser, Craig,Taggart, Andrew K.P.,Cheng, Kang,Carballo-Jane, Ester,Gerard Waters,Tata, James R.,Colletti, Steven L.
scheme or table, p. 2121 - 2124 (2009/12/03)
5-Alkyl and aryl-pyrazole-tetrazoles have been identified as a new class of selective, small-molecule, agonists of the human G-protein-coupled receptor GPR109a, a high affinity receptor for the HDL-raising drug nicotinic acid.
TETRAZOLE DERIVATIVES AND METHODS OF TREATMENT OF METABOLIC-RELATED DISORDERS THEREOF
-
Page/Page column 73, (2010/02/11)
The present invention relates to certain tetrazole derivatives of Formula (I), and pharmaceutically acceptable salts thereof, which exhibit useful pharmacological properties, for example, as agonists for the RUP25 receptor. Also provided by the present in
